Role of Endogenous Microbiota, Probiotics and Their Biological Products in Human Health
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Although gut diseases such as inflammatory bowel disease, mucositis and the alimentary cancers share similar pathogenetic features, further investigation is required into new treatment modalities. An imbalance in the gut microbiota, breached gut integrity, bacterial invasion, increased cell apoptosis to proliferation ratio, inflammation and impaired immunity may all contribute to their pathogenesis. Probiotics are defined as live bacteria, which when administered in sufficient amounts, exert beneficial effects to the gastrointestinal tract. More recently, probiotic-derived factors including proteins and other molecules released from living probiotics, have also been shown to exert beneficial properties. In this review we address the potential for probiotics, with an emphasis on probiotic-derived factors, to reduce the severity of digestive diseases and further discuss the known mechanisms by which probiotics and probiotic-derived factors exert their physiological effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212 · cited 1×
“P-glycoproten (P-gp) and other nucleotide signaling, which together play an important role in intestinal integrity [73,106,107].”
BackgroundDeath Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 2×
“However, unscheduled apoptosis of certain cells can be detrimental [52].”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“, Enterococcus faecium JWS 833 and Faecalibacterium prausnitzii [70–72] have been reported to maintain immune homeostasis through”
BackgroundInflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230 · cited 5×
“pro-inflammatory cytokines such as IL-1 and IL-18 [86].”
BackgroundInfluentialInduction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 3×
“Immunoglobulin A (IgA) is a major antibody that is secreted across intestinal mucosal linings, playing a critical role in mucosal immunity [67,68].”
BackgroundKruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285 · cited 1×
“Recent studies have found that the probiotic Escherichia coli Nissle 1917, a promising candidate for therapy against mucosal disorders [89,90], can induce DNA damage in vivo and trigger genomic instability and gene mutations in mammalian”
BackgroundEscherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells
Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188 · cited 2×
“cells [91,92].”
BackgroundManichanh, C., Borruel, N., Casellas, F., & Guarner, F. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.152 · Cited by 1,160 · cited 3×
“Diseases such as IBD and colon cancer may lead to disruption of the gut barrier [34].”
BackgroundHost interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2297 · Cited by 1,062 · cited 1×
“Glycosylation for Msp1 is hypothesized to be involved in various glycan-mediated interactions of LGG, such as targeting specific innate immune cells and food degradation by microbes [110,111].”
BackgroundMicrobial modulation of innate defense: goblet cells and the intestinal mucus layer
Deplancke, B., & Gaskins, H. R. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1131s · Cited by 1,012
Cited by
Improving End-User Trust in the Quality of Commercial Probiotic Products
Jackson, S. A., Schoeni, J. L., Vegge, C., Pane, M., Stahl, B., Bradley, M., Goldman, V. S., Burguière, P., Atwater, J. B., & Sanders, M. E. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00739 · Cited by 192
One health, fermented foods and gut microbiota
Bell, V., Ferrão, J., Pimentel, L., Pintado, M., & Fernandes, T. (2018) · Foods · doi:10.3390/foods7120195 · Cited by 188
“) favors homeostasis, particularly at the level of the disease–immune dialogue [52,53].”
BackgroundLefevre, M., Racedo, S. M., Ripert, G., Housez, B., Cazaubiel, M., Maudet, C., Jüsten, P., Marteau, P., & Urdaci, M. C. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0051-y · Cited by 147
“Probiotics have been suggested to protect against infectious diseases by several strain-dependant mechanisms [35, 36] including secretion of anti-pathogen substances, competitive exclusion of pathogens, maintenance of mucosal integrity and stimulation of systemic or mucosal immune responses [35–39].”
BackgroundTargeting the human gut microbiome with small-molecule inhibitors
Woo, A. Y. M., Aguilar Ramos, M. A., Narayan, R., Richards-Corke, K. C., Wang, M. L., Sandoval-Espinola, W. J., & Balskus, E. P. (2023) · Nature Reviews Chemistry · doi:10.1038/s41570-023-00471-4 · Cited by 42
Zielińska, D., Sionek, B., & Kołożyn-Krajewska, D. (2018) · Diet, Microbiome and Health · doi:10.1016/b978-0-12-811440-7.00006-5 · Cited by 34
Metadata
- Authors
- Howarth, G., & Wang, H.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2013-01-10
- Volume
- 5
- Issue
- 1
- Pages
- 58-81
- ISSN
- 2072-6643 (ISSN-L)
- OpenAlex
- W2164525467
- Cited by
- 141
- References
- 16
- FWCI
- 22.67
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.